DIANHYDROGALACTITOL AND RADIATION-THERAPY - TREATMENT OF SUPRATENTORIAL GLIOMA

被引:36
作者
EAGAN, RT
CHILDS, DS
LAYTON, DD
LAWS, ER
BISEL, HF
HOLBROOK, MA
FLEMING, TR
机构
[1] MAYO CLIN & MAYO FDN,DIV THERAPEUT RADIOL,ROCHESTER,MN 55901
[2] MAYO CLIN & MAYO FDN,NEUROL SECT,ROCHESTER,MN 55901
[3] MAYO CLIN & MAYO FDN,DEPT NEUROSURG,ROCHESTER,MN 55901
[4] MAYO CLIN & MAYO FDN,CTR CANC STAT,ROCHESTER,MN 55901
来源
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION | 1979年 / 241卷 / 19期
关键词
D O I
10.1001/jama.241.19.2046
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:2046 / 2050
页数:5
相关论文
共 12 条
  • [1] COX DR, 1972, J R STAT SOC B, V34, P187
  • [2] PHASE-1 STUDY OF A 5-DAY INTERMITTENT SCHEDULE FOR 1,2-5,6-DIANHYDROGALACTITOL (NSC-132313)
    EAGAN, RT
    MOERTEL, CG
    HAHN, RG
    SCHUTT, AJ
    [J]. JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1976, 56 (01) : 179 - 181
  • [3] GEHAN EA, 1965, BIOMETRIKA, V52, P203, DOI 10.1093/biomet/52.1-2.203
  • [4] GERAN RI, 1974, CANCER CHEMOTH REP 3, V4, P53
  • [5] GLIOBLASTOMA MULTIFORME - ITS TREATMENT AND SOME FACTORS EFFECTING SURVIVAL
    JELSMA, R
    BUCY, PC
    [J]. ARCHIVES OF NEUROLOGY, 1969, 20 (02) : 161 - &
  • [6] NONPARAMETRIC-ESTIMATION FROM INCOMPLETE OBSERVATIONS
    KAPLAN, EL
    MEIER, P
    [J]. JOURNAL OF THE AMERICAN STATISTICAL ASSOCIATION, 1958, 53 (282) : 457 - 481
  • [7] CONTROLLED-STUDY OF CCNU AND RADIATION-THERAPY IN MALIGNANT ASTROCYTOMA
    REAGAN, TJ
    BISEL, HF
    CHILDS, DS
    LAYTON, DD
    RHOTON, AL
    TAYLOR, WF
    [J]. JOURNAL OF NEUROSURGERY, 1976, 44 (02) : 186 - 190
  • [8] IMPORTANCE OF DISTINGUISHING TUMOR GRADE IN MALIGNANT GLIOMAS - TREATMENT AND PROGNOSIS
    SHELINE, GE
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1976, 1 (7-8): : 781 - 786
  • [9] RADIATION AND HIGH-DOSE METRONIDAZOLE IN SUPRATENTORIAL GLIOBLASTOMAS
    URTASUN, R
    BAND, P
    CHAPMAN, JD
    FELDSTEIN, ML
    MIELKE, B
    FRYER, C
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1976, 294 (25) : 1364 - 1367
  • [10] WALKER MD, 1976, CANCER TREAT REP, V60, P713